This underscores the potential relevance of other secondary genetic or epigenetic changes related to chromosome 8q in influencing patient outcomes, as suggested by Ehlers et al. [30], who showed that overexpression of the DDEF1 gene located at 8q24 increases cell motility and may act as an oncogene in this cancer. The gene discussed is ASAP1; the disease is cancer.